Seres Therapeutics, Inc.
MCRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001609809
In the last 90 days, Seres Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $17.9M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Seres Therapeutics, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 134 | 103 | −31 |
| Shares | 107.4M | 89.5M | −17.9M (−16.6%) |
| Value | $255.6M | $125.4M | −$130.2M (−50.9%) |
New holders (18)
Institutions that held Seres Therapeutics, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tang Capital Management LLC | 1,792,888 | $2.51M | 0.23% |
| Renaissance Technologies LLC | 817,000 | $1.14M | 0.00% |
| HRT Financial LP | 393,760 | $551.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 324,209 | $453.9K | 0.00% |
| Pennant Investors, LP | 292,300 | $409.2K | 0.13% |
| D. E. Shaw & Co., Inc. | 168,518 | $235.9K | 0.00% |
| Squarepoint Ops LLC | 114,000 | $159.6K | 0.00% |
| Acadian Asset Management LLC | 100,812 | $141.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 71,523 | $100.1K | 0.01% |
| Group One Trading, L.P. | 71,259 | $99.8K | 0.00% |
| Balyasny Asset Management LLC | 55,011 | $77.0K | 0.00% |
| SG Americas Securities, LLC | 52,080 | $73.0K | 0.00% |
| Point72 Middle East FZE | 39,004 | $54.6K | 0.00% |
| Wexford Capital LP | 20,440 | $28.6K | 0.01% |
| Stifel Financial Corp | 20,000 | $28.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 2,856 | $4.00K | 0.00% |
| Farther Finance Advisors, LLC | 3 | $4 | 0.00% |
| Providence Wealth Advisors, LLC | 675 | – | – |
Sold out (49)
Institutions that held Seres Therapeutics, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.